Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells.
Martínez-Avila
Olga
O
Laboratory of GlycoNanotechnology, CIC biomaGUNE/CIBER-BBN, P degrees Miramón 182, 20009 San Sebastián, Spain.
Bedoya
Luis M
LM
Marradi
Marco
M
Clavel
Caroline
C
Alcamí
José
J
Penadés
Soledad
S
D019380:Anti-HIV Agents / Q000737:chemistry* / Q000494:pharmacology; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002478:Cells, Cultured; D006046:Gold / Q000737:chemistry; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D037181:Lectins, C-Type / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008362:Mannosides / Q000737:chemistry* / Q000494:pharmacology; D053768:Metal Nanoparticles / Q000737:chemistry*; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology / Q000821:virology*; D000099215:DC-Specific ICAM-3 Grabbing Nonintegrin
D019380:Anti-HIV Agents; D015815:Cell Adhesion Molecules; D006046:Gold; D037181:Lectins, C-Type; D008362:Mannosides; D011956:Receptors, Cell Surface; D000099215:DC-Specific ICAM-3 Grabbing Nonintegrin